NICARDIPINE - A NEW CALCIUM-ANTAGONIST - CLOSING REMARKS

被引：0
|
作者：
JULIAN, D
机构：
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 22卷
关键词：
D O I：
10.1111/j.1365-2125.1986.tb00344.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [31] CARDIOVASCULAR EFFECTS OF NISOLDIPINE, A NEW CALCIUM-ANTAGONIST
    FEIGEN, LP
    KING, LW
    BECKETT, W
    KADOWITZ, PJ
    FEDERATION PROCEEDINGS, 1982, 41 (05) : 1648 - 1648
  • [32] ANTIATHEROSCLEROTIC EFFECTS OF NEW CALCIUM-ANTAGONIST, ANIPAMIL
    OREKHOV, AN
    TERTOV, VV
    ARTERIOSCLEROSIS, 1989, 9 (05): : A756 - A756
  • [33] EFFECTIVENESS OF A NEW CALCIUM-ANTAGONIST IN SEVERE HYPERTENSION
    BURRIS, JF
    SANTANGELO, RP
    MROCZEK, WJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 26 (08): : 593 - 597
  • [34] EXPERIENCE WITH NITRENDIPINE - A NEW CALCIUM-ANTAGONIST - IN HYPERTENSION
    ANDREN, L
    HANSSON, L
    ORO, L
    RYMAN, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 : S387 - S391
  • [35] HEMOLYSIS ON INTRAVENOUS ADMINISTRATION OF A NEW CALCIUM-ANTAGONIST
    KLEINBLOESEM, CH
    SIEPMANN, M
    KIRCH, W
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 25 (06) : 855 - 858
  • [36] INTERACTION OF NISOLDIPINE, A NEW CALCIUM-ANTAGONIST, WITH DIGOXIN
    KIRCH, W
    HUTT, RJ
    SANTOS, SR
    OHNHAUS, EE
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 179 - 179
  • [37] PHARMACODYNAMICS OF A CALCIUM-ANTAGONIST OF A NEW CHEMICAL CLASS
    BELZ, GG
    ERB, K
    BREITHAUPT, K
    BUTZER, R
    SCHMITT, R
    KLEINBLOESEM, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) : 198 - 198
  • [38] NEW CALCIUM-ANTAGONIST DRUG - CHLORHYDRATE OF FONDILINE
    HAIAT, R
    DESOUTTER, P
    STOLTZ, JP
    COEUR, 1981, 12 (02): : 232 - 232
  • [39] ANTIHYPERTENSIVE EFFECTS OF AMLODIPINE, A NEW CALCIUM-ANTAGONIST
    YAMANAKA, K
    SUZUKI, M
    MUNEHASU, S
    ISHIKO, J
    FOLIA PHARMACOLOGICA JAPONICA, 1991, 97 (02) : 115 - 126
  • [40] NILVADIPINE - PROFILE OF A NEW CALCIUM-ANTAGONIST - AN OVERVIEW
    ROSENTHAL, J
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 : S92 - S107
12345